Current smoking cessation guideline bodies (including the American Lung Association) continue to recommend varenicline, bupropion, and nicotine replacement therapy as evidence-based first-line treatments
Still, researchers point out that these trials involved people with established cognitive symptoms, and its possible GLP1 drugs might be more effective if given earlier, before the neurological damage is advanced
As a modeled estimate (extrapolating survey incidence to 2025 adult population estimates), this suggests 28M+ adults in the U.S
CrossRef The regulatory role of circGDI2 in hepatocellular carcinoma proliferation and glycolysis with the involvement of m6A modification Shiyi Chen, Hongxiang Xia, Shuwei Chen Non-coding RNA Research .2026
Research Area Workflow Stages Quality Statement: PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED.